Sphingosine 1-phosphate receptor 1 governs endothelial barrier function and angiogenesis by upregulating endoglin signaling

Background The sphingosine 1-phosphate (S1P)/S1P receptor (S1pr) 1 signaling plays an essential role in regulating vascular integrity and angiogenesis. We have previously shown that cell-surface expression of endoglin (Eng) is sustained by S1P/S1pr1 signaling in endothelial cells (ECs). However, whether S1pr1 mediates Eng signaling, or vice versa, remains unknown. Methods S1pr1 inhibitors were used to study whether pharmacological inhibition induces basal vascular leakage in vivo. An acute respiratory distress syndrome (ARDS) model was used to study whether S1pr1 inhibition evoked greater inflammation in lungs. A S1pr1 inhibitor, a bone morphogenetic protein 9 (BMP9) blocking antibody, or lentivirus-mediated expression of soluble extracellular domain of Eng (sEng) were used to test whether blocking both S1P/S1pr1 and BMP9/Eng signaling axes would impose any interaction in retinal angiogenesis. To clarify whether S1P and BMP9 function in a linear pathway, a study of trans-endothelial electrical resistance (TEER) measurement was carried out using a mouse islet EC line MS1; time course studies were executed to exam downstream effectors of S1P and BMP9 signaling pathways in ECs; two stable MS1 cell lines were generated, one with overexpression of human S1PR1 and the other with knockdown of Eng, to validate S1pr1 and Eng were the key players for the crosstalk. Inhibitor of extracellular regulated protein kinases (ERK) was used to check whether this signaling was involved in S1P-induced cell-surface localization of Eng. Results The present study elucidated that S1pr1 and Eng are both pivotal for angiogenesis in the postnatal mouse retina, and that the activation of S1pr1 or Eng increases vascular barrier function. Activation of S1pr1 enhanced the phosphorylation of Smad family members 1, 5, and 8 (pSmad1/5/8), while the inhibition of S1pr1 reduced the levels of pSma1/5/8 induced by BMP9 treatment. Activation or loss of Eng did not affect S1pr1 signaling. Moreover, activation of ERK was involved in promoting EC-surface expression of Eng by S1pr1. Conclusions Our data demonstrates for the first time that there exists a linear pathway of S1pr1-Eng signaling axis in ECs, which governs vascular homeostasis. Functional BMP9/Eng signaling requires S1P/S1pr1 activation, and S1pr1 signaling acts as a vascular protection mechanism upstream of Eng.

[1]  T. Hla,et al.  Endothelial sphingosine 1-phosphate receptors promote vascular normalization and antitumor therapy , 2020, Proceedings of the National Academy of Sciences.

[2]  S. Butz,et al.  Interference With ESAM (Endothelial Cell-Selective Adhesion Molecule) Plus Vascular Endothelial-Cadherin Causes Immediate Lethality and Lung-Specific Blood Coagulation , 2019, Arteriosclerosis, thrombosis, and vascular biology.

[3]  T. Hla,et al.  Sphingosine 1-phosphate: Lipid signaling in pathology and therapy , 2019, Science.

[4]  T. Hla,et al.  Sphingosine 1-phosphate receptor 1 regulates cell-surface localization of membrane proteins in endothelial cells. , 2019, Biochimica et biophysica acta. General subjects.

[5]  S. Swendeman,et al.  Sphingosine 1‐Phosphate Receptor 1 Signaling Maintains Endothelial Cell Barrier Function and Protects Against Immune Complex–Induced Vascular Injury , 2018, Arthritis & rheumatology.

[6]  H. Arthur,et al.  Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia , 2018, Disease Models & Mechanisms.

[7]  Agnès Desroches-Castan,et al.  BMP9, but not BMP10, acts as a quiescence factor on tumor growth, vessel normalization and metastasis in a mouse model of breast cancer , 2018, Journal of Experimental & Clinical Cancer Research.

[8]  B. Larrivée,et al.  BMP9 (Bone Morphogenetic Protein-9)/Alk1 (Activin-Like Kinase Receptor Type I) Signaling Prevents Hyperglycemia-Induced Vascular Permeability , 2018, Arteriosclerosis, thrombosis, and vascular biology.

[9]  R. Pastori,et al.  Intra‐Amniotic Soluble Endoglin Impairs Lung Development in Neonatal Rats , 2017, American journal of respiratory cell and molecular biology.

[10]  C. Betsholtz,et al.  Endoglin prevents vascular malformation by regulating flow-induced cell migration and specification through VEGFR2 signalling , 2017, Nature Cell Biology.

[11]  C. Iadecola,et al.  Size-selective opening of the blood–brain barrier by targeting endothelial sphingosine 1–phosphate receptor 1 , 2017, Proceedings of the National Academy of Sciences.

[12]  P. D’Amore,et al.  Disorders of Vascular Permeability. , 2016, Annual review of pathology.

[13]  Lloyd H. Michael,et al.  The Guide for the Care and Use of Laboratory Animals. , 2016, ILAR journal.

[14]  K. Brown,et al.  Selective deletion of the endothelial sphingosine-1-phosphate 1 receptor exacerbates kidney ischemia-reperfusion injury , 2013, Kidney international.

[15]  John Greenwood,et al.  LRG1 promotes angiogenesis by modulating endothelial TGFß signalling , 2013, Nature.

[16]  R. Stevens,et al.  Sphingosine-1-phosphate and its receptors: structure, signaling, and influence. , 2013, Annual review of biochemistry.

[17]  M. Goumans,et al.  Deficiency for endoglin in tumor vasculature weakens the endothelial barrier to metastatic dissemination , 2013, The Journal of experimental medicine.

[18]  W. Zhong,et al.  Endoglin Requirement for BMP9 Signaling in Endothelial Cells Reveals New Mechanism of Action for Selective Anti-Endoglin Antibodies , 2012, PloS one.

[19]  R. Hersperger,et al.  A potent and selective S1P(1) antagonist with efficacy in experimental autoimmune encephalomyelitis. , 2012, Chemistry & biology.

[20]  S. Rafii,et al.  Flow-regulated endothelial S1P receptor-1 signaling sustains vascular development. , 2012, Developmental cell.

[21]  C. Betsholtz,et al.  The sphingosine-1-phosphate receptor S1PR1 restricts sprouting angiogenesis by regulating the interplay between VE-cadherin and VEGFR2. , 2012, Developmental cell.

[22]  T. Zimmers,et al.  BMP9 and BMP10 are critical for postnatal retinal vascular remodeling. , 2012, Blood.

[23]  Laure Gambardella,et al.  A Computational Tool for Quantitative Analysis of Vascular Networks , 2011, PloS one.

[24]  T. Hla,et al.  Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors. , 2011, Chemical reviews.

[25]  T. Hla,et al.  Engagement of S1P₁-degradative mechanisms leads to vascular leak in mice. , 2011, The Journal of clinical investigation.

[26]  R. Adams,et al.  Inducible gene targeting in the neonatal vasculature and analysis of retinal angiogenesis in mice , 2010, Nature Protocols.

[27]  Rachael J. Oakenfull,et al.  Pathogenesis of Arteriovenous Malformations in the Absence of Endoglin , 2010, Circulation research.

[28]  S. Coughlin,et al.  Sphingosine-1-phosphate in the plasma compartment regulates basal and inflammation-induced vascular leak in mice. , 2009, The Journal of clinical investigation.

[29]  Elisabetta Dejana,et al.  The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. , 2009, Developmental cell.

[30]  G. Blobe,et al.  Endoglin Promotes Transforming Growth Factor β-mediated Smad 1/5/8 Signaling and Inhibits Endothelial Cell Migration through Its Association with GIPC* , 2008, Journal of Biological Chemistry.

[31]  Ian Parker,et al.  Enhancement of capillary leakage and restoration of lymphocyte egress by a chiral S1P1 antagonist in vivo , 2006, Nature chemical biology.

[32]  A. Parrill,et al.  S1P1-selective in vivo-active agonists from high-throughput screening: off-the-shelf chemical probes of receptor interactions, signaling, and fate. , 2005, Chemistry & biology.

[33]  M. Goumans,et al.  Endoglin promotes endothelial cell proliferation and TGF‐β/ALK1 signal transduction , 2004, The EMBO journal.

[34]  R. Proia,et al.  G-protein-coupled receptor S1P1 acts within endothelial cells to regulate vascular maturation. , 2003, Blood.

[35]  Michael D. Davis,et al.  The Immune Modulator FTY720 Targets Sphingosine 1-Phosphate Receptors* , 2002, The Journal of Biological Chemistry.

[36]  J. P. Hobson,et al.  Edg-1, the G protein-coupled receptor for sphingosine-1-phosphate, is essential for vascular maturation. , 2000, The Journal of clinical investigation.

[37]  P. Carmeliet Mechanisms of angiogenesis and arteriogenesis , 2000, Nature Medicine.

[38]  D. Dumont,et al.  A murine model of hereditary hemorrhagic telangiectasia. , 1999, The Journal of clinical investigation.

[39]  B. Brooke,et al.  Defective angiogenesis in mice lacking endoglin. , 1999, Science.

[40]  D. W. Johnson,et al.  Endoglin, a TGF-β binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1 , 1994, Nature Genetics.